Low Real-World Use of SGLT2 Inhibitors in People with Diabetes and Heart Failure-A Population Cohort Study

被引：0
|
作者：
Butalia, Sonia
Wen, Chuan
Senior, Peter A.
Sigal, Ronald J.
Quan, Hude
Chu, Manh Luan
Kaul, Padma
机构：
来源：
DIABETES | 2023年 / 72卷
关键词：
D O I：
10.2337/db23-1230-P
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1230-P
引用
收藏
页数：2
相关论文
共 50 条
  • [1] SGLT2 Inhibitors in Type 2 Diabetes Mellitus and Heart Failure-A Concise Review
    Keller, Daria M.
    Ahmed, Natasha
    Tariq, Hamza
    Walgamage, Malsha
    Walgamage, Thilini
    Mohammed, Azad
    Chou, Jadzia Tin-Tsen
    Kaluzna-Oleksy, Marta
    Lesiak, Maciej
    Straburzynska-Migaj, Ewa
    [J]. JOURNAL OF CLINICAL MEDICINE, 2022, 11 (06)
  • [2] SGLT2 inhibitors and vericiguat in real-world patients admitted for worsening heart failure
    Tarantini, R.
    Acone, L.
    Alonge, S.
    Catagnano, F.
    Foti, M.
    Oldani, M.
    Mortara, A.
    [J]. EUROPEAN HEART JOURNAL, 2023, 44
  • [3] SGLT2 inhibitors in real-world patients with heart failure with preserved ejection fraction
    Tarantini, R.
    Vecchi, A. L.
    Matteo, F.
    De Ponti, R.
    Mortara, A.
    [J]. EUROPEAN HEART JOURNAL, 2022, 43 : 779 - 779
  • [4] Real-World Study on the Effect of SGLT2 Inhibitors in Patients with Type 2 Diabetes in China
    Xue, Yaoming
    Shi, Lixin
    Yu, Xuefeng
    Wang, Yangang
    Hong, Tianpei
    Li, Xiaoying
    Ma, Jianhua
    Zhu, Dalong
    Mu, Yiming
    [J]. DIABETES, 2024, 73
  • [5] HEART FAILURE, DIABETES AND USE OF SGLT2 INHIBITORS - A MISSED OPPORTUNITY
    Coomer, Soham
    Jain, Shruti
    Tun, Thet
    Kumar, Somnath
    [J]. HEART, 2020, 106 : A79 - A80
  • [6] Predictors and Outcomes of SGLT2 Inhibitor Discontinuation in a Real-World Population after Hospitalization for Heart Failure
    Nakagaito, Masaki
    Imamura, Teruhiko
    Ushijima, Ryuichi
    Nakamura, Makiko
    Kinugawa, Koichiro
    [J]. BIOMEDICINES, 2023, 11 (03)
  • [7] Pioglitazone, SGLT2 inhibitors and their combination for primary prevention of cardiovascular disease and heart failure in type 2 diabetes: Real-world evidence from a nationwide cohort database
    Lo, Shih-Chang
    Kornelius, Edy
    Liao, Pei-Lun
    Huang, Jing-Yang
    Yang, Yi-Sun
    Huang, Chien-Ning
    [J]. DIABETES RESEARCH AND CLINICAL PRACTICE, 2023, 200
  • [8] Real-world efficacy and safety of SGLT2 inhibitors in type 1 diabetes: a two-center cohort retrospective study
    van Nes, F.
    Palanca, A.
    Ampudia-Blasco, F.
    Pardo, F.
    Real, J.
    Mathieu, C.
    [J]. DIABETOLOGIA, 2021, 64 (SUPPL 1) : 259 - 260
  • [9] A real-world study on SGLT2 inhibitors and diabetic kidney disease progression
    Liu, Allen Yan Lun
    Low, Serena
    Yeoh, Ester
    Lim, Eng Kuang
    Renaud, Claude Jeffrey
    Teoh, Selene Tse Yen
    Tan, Grace Feng Ling
    Chai, Chung Cheen
    Liu, Bo
    Subramaniam, Tavintharan
    Sum, Chee Fang
    Lim, Su Chi
    [J]. CLINICAL KIDNEY JOURNAL, 2022, 15 (07) : 1403 - 1414
  • [10] Promise of SGLT2 Inhibitors in Heart Failure: Diabetes and Beyond
    Martens P.
    Mathieu C.
    Verbrugge F.H.
    [J]. Current Treatment Options in Cardiovascular Medicine, 2017, 19 (3)
12345